Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE host genome working group
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Familial Cancer, 20, S. 305-316
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2021
- Event
-
Veröffentlichung
- (who)
-
Springer Science and Business Media LLC
- (when)
-
2021
- Creator
-
Frühwald, Michael
Nemes, K.
Boztug, H.
Cornips, M. C. A.
Evans, D. G.
Farah, R.
Glentis, S.
Jorgensen, M.
Katsibardi, K.
Hirsch, S.
Jahnukainen, K.
Kventsel, I.
Kerl, K.
Kratz, C. P.
Pajtler, Kristian Wilfried
Kordes, U.
Ridola, V.
Stutz, E.
Bourdeaut, F.
- DOI
-
10.1007/s10689-021-00229-1
- URN
-
urn:nbn:de:bvb:384-opus4-835008
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Frühwald, Michael
- Nemes, K.
- Boztug, H.
- Cornips, M. C. A.
- Evans, D. G.
- Farah, R.
- Glentis, S.
- Jorgensen, M.
- Katsibardi, K.
- Hirsch, S.
- Jahnukainen, K.
- Kventsel, I.
- Kerl, K.
- Kratz, C. P.
- Pajtler, Kristian Wilfried
- Kordes, U.
- Ridola, V.
- Stutz, E.
- Bourdeaut, F.
- Universität Augsburg
- Springer Science and Business Media LLC
Time of origin
- 2021
Other Objects (12)
Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group
BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors
Bridging molecular advancements and clinical challenges in pediatric oncology
Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors
The need for tumor surveillance of children and adolescents with cancer predisposition syndromes: a retrospective cohort study in a tertiary-care children’s hospital
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy
Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus
A retrospective 5-year single center study highlighting the risk of cancer predisposition in adolescents and young adults
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
SWI/SNF-Komplex-assoziierte Tumordispositions-Syndrome
Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group
BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors
Bridging molecular advancements and clinical challenges in pediatric oncology
Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors
The need for tumor surveillance of children and adolescents with cancer predisposition syndromes: a retrospective cohort study in a tertiary-care children’s hospital
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy
Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus
A retrospective 5-year single center study highlighting the risk of cancer predisposition in adolescents and young adults
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
SWI/SNF-Komplex-assoziierte Tumordispositions-Syndrome
Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group
BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors
Bridging molecular advancements and clinical challenges in pediatric oncology
Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors
The need for tumor surveillance of children and adolescents with cancer predisposition syndromes: a retrospective cohort study in a tertiary-care children’s hospital
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy
Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus
A retrospective 5-year single center study highlighting the risk of cancer predisposition in adolescents and young adults
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor